Stakeholders Innovate on Hemostasis Valves for Future Therapeutic Catheter Development Projects
Hemostasis valves aid healthcare providers in delivering efficiency in next-generation catheter and delivery systems. Stakeholders in the hemostasis valves market are increasing research and development to offer innovative devices with new designs that cater to consumer needs and are easily adjustable.
Likewise, minimally-invasive technologies in hemostasis valves facilitate improved procedural workflow and enhanced tactile feel and control. This technology ensures the prolonged durability of hemostasis valves, and maintains the hemostasis even after multiple or large catheter insertions. As such, stakeholders are developing value-added features such as single user and single handed operations for hemostasis valves.
To leverage the use of minimally-invasive hemostasis valves in catheter systems, manufacturers are developing valve assemblies that easily integrate into the catheter and delivery system. Thus, innovations in hemostasis valves can be integrated for future therapeutic catheter development projects to give rise to new design options and shorten the development time. For instance, in May 2019, Merit Medical Systems Inc. - a global leader in the medical device industry, announced the launch of the PhD™ (Push, Hold, Deliver) polycarbonate hemostasis valve, which allows doctors and healthcare providers to operate the valve with one hand during insertion and withdrawal of diagnostic or interventional devices.
To know the scope of our report Get a Sample on Hemostasis Valves Market
Advances in Device Designs Trigger Applications in Endovascular Treatment
Ongoing research and development is being carried out by manufacturers to develop robust hemostasis valves that provide efficient vascular access applications. New designs in catheter-supported hemostasis valves are being developed to try to overcome unique challenges in trans-catheter valves and the endovascular landscape, such as large perforate vascular access and delivery systems. Thus, the increasing size of emerging therapeutic devices is leading to innovations and novel solutions to reduce risk and improve outcomes through high-end catheter-supported hemostasis valves.
As such, stakeholders are collaborating with research experts to brainstorm on the unmet clinical needs and offer healthcare providers with a growing portfolio of cutting-edge hemostasis valves with improved device designs. For instance, Freudenberg Medical, LLC - a leading manufacturer of medical devices, announced the launch of Composer® XL and HyperSeal® XL, to address the challenges of large perforate vascular access and device delivery in trans-catheter valve and endovascular applications.
Get a glimpse of the in-depth analysis through our Report Brochure?
Manufacturers Overcome Functional Limitations by Increasing Offerings in Existing Products
Although the hemostasis valves ecosystem has seen tremendous developments in transforming the way valves function, there are certain limitations in specialized treatments. Since a hemostasis valve is a component of the microcatheter facilitated reverse wire technique to operate bifurcated lesions, it is challenging for healthcare providers to treat percutaneous coronary intervention, especially with severe proximal stenosis. However, it is suggested that, the crusade microcatheter facilitated reverse wise technique with short tip one curve is an efficient and safe way of wiring in solving angulated bifurcated lesions.
Apart from innovations in hemostasis valves, manufacturers are developing dual valve adapters designed to function with sheath introducers. With the help of two separate valves, doctors can operate and control multiple devices while maintaining a secure seal that stops leaks. Dual valve adapters fix perfectly on the sheath cap to avoid leaks during interventions, and are compatible with multiple sized devices.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
Analysts of the hemostasis valves market have a positive outlook for the growth of the market during the forecast period of 2019-2027. Ongoing research and developments are being made to increase offerings in minimally-invasive technologies for hemostasis valves in catheter systems. The emergence of new cath labs in North America, Europe, and Asia Pacific are anticipated to increase the demand for hemostasis valves in high-end catheter systems. However, the functional limitations of hemostasis valves in the microcatheter-facilitated reverse wire technique for specialized treatments still pose as a restraint. As such, stakeholders are innovating in double valve and Y connector products in the hemostasis valves ecocystem.
Hemostasis Valves: Overview
Hemostasis valves are used to minimize blood loss during the introduction, withdrawal, and use of devices in interventional and diagnostic procedures. These are extensively utilized in interventional procedures such as percutaneous transluminal coronary angioplasty, to create an entrance and minimize blood loss when interventional devices are inserted into the human vasculature.
Strategic Acquisitions and Partnerships to Drive Hemostasis Valves Market
- The global hemostasis valves market was valued at ~US$ 135 Mn in 2018. The global hemostasis valves market is projected to reach ~US$ 207 Mn by 2027, expanding at a CAGR of ~5% from 2019 to 2027.
- Strategic acquisitions by service providers have enabled them to consolidate their position in the hemostasis valves market, increase service offerings, and strengthen their customer base. For instance, in May 2019, Argon Medical announced the acquisition of Mana-Tech, Ltd., its exclusive distributor for the U.K. and Ireland. This acquisition of Mana-Tech, Ltd. is expected to offer significant opportunity to the company to expand its presence in the U.K., Ireland, and across Europe.
- In May 18, 2018, Merit Medical Systems, Inc. entered into a distribution agreement with QXMédical, LLC for the exclusive global distribution rights to the Q50 PLUS Stent Graft Balloon Catheter. The Q50 PLUS is utilized in abdominal and thoracic endovascular aneurysm repair procedures to repair abdominal aortic aneurysms and thoracic aortic aneurysms.
- In March 2018, Boston Scientific Corporation acquired EMcision Limited, a privately-held company operating in the U.S. and Canada. This acquisition is expected to enhance the company’s endoscopic portfolio with the inclusion of radiofrequency devices.
New Products to Propel Hemostasis Valves Market
- In December 2017, Freudenberg Medical introduced new hemostasis valves for interventional and diagnostic procedures. The new hemostasis valve family enhances the innovative HyperSeal and CertuSeal valves to the well-received FlexSeal valve that was launched in 2016. The company also launched new HyperSeal Introducer Sheath with hydrophilic coating, which joins the FlexSeal Introducer Sheath as a white label device solution for large bore procedures.
- Boston Scientific Corporation launched Resolution 360 Clip, a hemostasis clip designed for more accurate clip placement for the treatment of upper and lower gastrointestinal bleeding.
- The introduction of new and innovative products is likely to fuel the global hemostasis valves market.
Hemostasis Valves Market: Expansion of Production Facilities
- In April 2018, B. Braun Melsungen AG established five new medical production facilities in Penang, Malaysia. These new state-of-the art facilities, featuring advanced building and production technologies, are expected to manufacture medical devices for infusion therapy, pharmaceutical solutions, and surgical instruments.
- In November 2018, Freudenberg Medical announced the construction of a new medical facility in Boston, U.S. The Boston area is a leading medical device and biotech cluster, globally, with a high concentration of universities and research centers. Moreover, this new operation facility would be FDA-registered and ISO 13485 certified, with ISO Class 8 clean rooms for medical molding and assembly.
Global Hemostasis Valves Market: North America to Account for Leading Market Share
- The report offers detailed segmentation of the global hemostasis valves market based on product, application, end user, and region
- Based on product, the global hemostasis valves market has been categorized into y connector hemostasis valves, double Y connector hemostasis valves, one-handed hemostasis valves, and others. Based on application, the global hemostasis valves market has been classified into diagnostic and interventional. In terms of end user, the global hemostasis valves market has been divided into hospitals, ambulatory surgical centers, and others.
- In terms of region, the global hemostasis valves market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to lead the global hemostasis valves market throughout the forecast period.
Hemostasis Valves Market: Companies Mentioned in the Report
The report provides profiles of the leading players operating in the global hemostasis valves market. These include
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Teleflex Incorporated
- Terumo Corporation
- Merit Medical Systems, Inc
- Freudenberg Medical
- ARGON MEDICAL.
Hemostasis Valves Market: Segmentation
The global hemostasis valves market has been bifurcated on the basis of product, application, end use, and region. Each of these segments are analyzed to provide readers a holistic view of the industry.
|
Product |
Y Connector Hemostasis Valves Double Connector Hemostasis Valves One-handed Hemostasis Valves Others |
|
Application |
Diagnostic Interventional |
|
End User |
Hospitals Ambulatory Surgical Centers Others |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa
|
Frequently Asked Questions
What is the total market worth of hemostasis valves market?
The global hemostasis valves market was worth US$ 135 Mn and is projected to reach a value of US$ 207 Mn by the end of 2027
What is the anticipated CAGR of hemostasis valves market in forecast period?
Hemostasis valves market is anticipated to grow at a CAGR of 4.5% during the forecast period
Which region is expected to project highest market share in hemostasis valves market?
North America accounted for a major share of the global hemostasis valves market
What are the key driving factors for growth of hemostasis valves market?
Hemostasis valves market is driven by increase in awareness about the early diagnosis of chronic diseases and rise in the number of angiography procedures are boosting the global market
Who are the key players in the global hemostasis valves market?
Key players in the global hemostasis valves market include Boston Scientific Corporation, B. Braun Melsungen AG, and Teleflex Incorporated - Leading Manufacturers of Hemostasis Valves
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemostasis Valves Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemostasis Valves Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Healthcare Industry Overview
5.2. Regulatory Scenario by Region/globally
6. Global Hemostasis Valves Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Hemostasis Valves Market Value Forecast, by Product, 2017–2027
6.3.1. Y Connector Hemostasis Valves
6.3.2. Double Y Connector Hemostasis Valves
6.3.3. One-handed Hemostasis Valves
6.3.4. Others
6.4. Global Hemostasis Valves Market Attractiveness, by Product
7. Global Hemostasis Valves Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Hemostasis Valves Market Value Forecast, by Application, 2017–2027
7.3.1. Diagnostic
7.3.2. Interventional
7.4. Global Hemostasis Valves Market Attractiveness, by Application
8. Global Hemostasis Valves Market Analysis and Forecast, by End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Hemostasis Valves Market Value Forecast, by End User, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Others
8.4. Global Hemostasis Valves Market Attractiveness, by End User
9. Global Hemostasis Valves Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Hemostasis Valves Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Hemostasis Valves Market Attractiveness, by Region
10. North America Hemostasis Valves Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Hemostasis Valves Market Value Forecast, by Product, 2017–2027
10.2.1. Y Connector Hemostasis Valves
10.2.2. Double Y Connector Hemostasis Valves
10.2.3. One-handed Hemostasis Valves
10.2.4. Others
10.3. North America Hemostasis Valves Market Value Forecast, by Application, 2017–2027
10.3.1. Diagnostic
10.3.2. Interventional
10.4. North America Hemostasis Valves Market Value Forecast, by End User, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Others
10.5. North America Hemostasis Valves Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Hemostasis Valves Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End User
10.6.4. By Country
11. Europe Hemostasis Valves Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Hemostasis Valves Market Value Forecast, by Product, 2017–2027
11.2.1. Y Connector Hemostasis Valves
11.2.2. Double Y Connector Hemostasis Valves
11.2.3. One-handed Hemostasis Valves
11.2.4. Others
11.3. Europe Hemostasis Valves Market Value Forecast, by Application, 2017–2027
11.3.1. Diagnostic
11.3.2. Interventional
11.4. Europe Hemostasis Valves Market Value Forecast, by End User, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Others
11.5. Europe Hemostasis Valves Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Hemostasis Valves Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End User
11.6.4. By Country/Sub-region
12. Asia Pacific Hemostasis Valves Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Hemostasis Valves Market Value Forecast, by Product, 2017–2027
12.2.1. Y Connector Hemostasis Valves
12.2.2. Double Y Connector Hemostasis Valves
12.2.3. One-handed Hemostasis Valves
12.2.4. Others
12.3. Asia Pacific Hemostasis Valves Market Value Forecast, by Application, 2017–2027
12.3.1. Diagnostic
12.3.2. Interventional
12.4. Asia Pacific Hemostasis Valves Market Value Forecast, by End User, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Others
12.5. Asia Pacific Hemostasis Valves Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Hemostasis Valves Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End User
12.6.4. By Country/Sub-region
13. Latin America Hemostasis Valves Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Hemostasis Valves Market Value Forecast, by Product, 2017–2027
13.2.1. Y Connector Hemostasis Valves
13.2.2. Double Y Connector Hemostasis Valves
13.2.3. One-handed Hemostasis Valves
13.2.4. Others
13.3. Latin America Hemostasis Valves Market Value Forecast, by Application, 2017–2027
13.3.1. Diagnostic
13.3.2. Interventional
13.4. Latin America Hemostasis Valves Market Value Forecast, by End User, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Others
13.5. Latin America Hemostasis Valves Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Hemostasis Valves Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End User
13.6.4. By Country/Sub-region
14. Middle East & Africa Hemostasis Valves Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Hemostasis Valves Market Value Forecast, by Product, 2017–2027
14.2.1. Y Connector Hemostasis Valves
14.2.2. Double Y Connector Hemostasis Valves
14.2.3. One-handed Hemostasis Valves
14.2.4. Others
14.3. Middle East & Africa Hemostasis Valves Market Value Forecast, by Application, 2017–2027
14.3.1. Diagnostic
14.3.2. Interventional
14.4. Middle East & Africa Hemostasis Valves Market Value Forecast, by End User, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Others
14.5. Middle East & Africa Hemostasis Valves Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Hemostasis Valves Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End User
14.6.4. By Country/Sub-region
14.7. Company Profiles
14.7.1. B. Braun Melsungen AG
14.7.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.1.2. Financial Overview
14.7.1.3. SWOT Analysis
14.7.1.4. Strategic Overview
14.7.2. Boston Scientific Corporation
14.7.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.2.2. Financial Overview
14.7.2.3. SWOT Analysis
14.7.2.4. Strategic Overview
14.7.3. Teleflex Incorporated
14.7.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.3.2. Financial Overview
14.7.3.3. SWOT Analysis
14.7.3.4. Strategic Overview
14.7.4. Terumo Corporation
14.7.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.4.2. Financial Overview
14.7.4.3. SWOT Analysis
14.7.4.4. Strategic Overview
14.7.5. Merit Medical Systems, Inc.
14.7.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.5.2. Financial Overview
14.7.5.3. SWOT Analysis
14.7.5.4 Strategic Overview
14.7.6. Freudenberg Medical
14.7.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.6.2. Financial Overview
14.7.5.3. SWOT Analysis
14.7.6.4 Strategic Overview
14.7.7. ARGON MEDICAL
14.7.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.7.7.2. Financial Overview
14.7.7.3. SWOT Analysis
14.7.7.4 Strategic Overview
List of Tables
Table 01: Global Hemostasis Valves Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Hemostasis Valves Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 03: Global Hemostasis Valves Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 04: Global Hemostasis Valves Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America Hemostasis Valves Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 06: North America Hemostasis Valves Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 07: North America Hemostasis Valves Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: North America Hemostasis Valves Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 09: Europe Hemostasis Valves Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: Europe Hemostasis Valves Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: Europe Hemostasis Valves Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 12: Europe Hemostasis Valves Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 13: Asia Pacific Hemostasis Valves Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Asia Pacific Hemostasis Valves Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Asia Pacific Hemostasis Valves Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 16: Asia Pacific Hemostasis Valves Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 17: Latin America Hemostasis Valves Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Latin America Hemostasis Valves Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Latin America Hemostasis Valves Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Latin America Hemostasis Valves Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 21: Middle East & Africa Hemostasis Valves Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Middle East & Africa Hemostasis Valves Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Middle East & Africa Hemostasis Valves Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 24: Middle East & Africa Hemostasis Valves Market Value (US$ Mn) Forecast, by End User, 2017?2027
List of Figures
Figure 01: Global Hemostasis Valves Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Hemostasis Valves Market Revenue Projection (US$ Mn), 2017–2027
Figure 03: Global Hemostasis Valves Market Value Share, by Product, 2018
Figure 04: Global Hemostasis Valves Market Value Share, by Application, 2018
Figure 05: Global Hemostasis Valves Market Value Share, by Region, 2018
Figure 06: Global Hemostasis Valves Market Value Share, by End User, 2018
Figure 07: Global Hemostasis Valves Market Value Share (%), by Product, 2018 and 2027
Figure 08: Global Hemostasis Valves Market Value (US$ Mn), by Y Connector Hemostasis Valves, 2017–2027
Figure 09: Global Hemostasis Valves Market Value (US$ Mn), by Double Y Connector Hemostasis Valves, 2017–2027
Figure 10: Global Hemostasis Valves Market Value (US$ Mn), by One-handed Hemostasis Valves, 2017–2027
Figure 11: Global Hemostasis Valves Market Value (US$ Mn), by Others, 2017–2027
Figure 12: Global Hemostasis Valves Market Attractiveness, by Product, 2019?2027
Figure 13: Global Hemostasis Valves Market Value Share (%), by Application, 2018 and 2027
Figure 14: Global Hemostasis Valves Market Value (US$ Mn), by Diagnostic, 2017–2027
Figure 15: Global Hemostasis Valves Market Value (US$ Mn), by Interventional, 2017–2027
Figure 16: Global Hemostasis Valves Market Attractiveness, by Application, 2019?2027
Figure 17: Global Hemostasis Valves Market Value Share (%), by End User, 2018 and 2027
Figure 18: Global Hemostasis Valves Market Value (US$ Mn), by Hospitals, 2017–2027
Figure 19: Global Hemostasis Valves Market Value (US$ Mn), by Ambulatory Surgery Centers
Figure 20: Global Hemostasis Valves Market Value (US$ Mn), by Others, 2017–2027
Figure 21: Global Hemostasis Valves Market Attractiveness, by End User, 2019?2027
Figure 22: Global Hemostasis Valves Market Value Share Analysis, by Region, 2018 and 2027
Figure 23: Global Hemostasis Valves Market Attractiveness Analysis, by Region, 2019–2027
Figure 24: North America Hemostasis Valves Market Value (US$ Mn), 2017–2027
Figure 25: North America Hemostasis Valves Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 26: North America Hemostasis Valves Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 27: North America Hemostasis Valves Market Value Share (%), by Application, 2018 and 2027
Figure 28: North America Hemostasis Valves Market Attractiveness, by Application, 2019–2027
Figure 29: North America Hemostasis Valves Market Value Share Analysis, by Product, 2018 and 2027
Figure 30: North America Hemostasis Valves Market Attractiveness Analysis, by Product, 2019–2027
Figure 31: North America Hemostasis Valves Market Value Share (%), by End User, 2018 and 2027
Figure 32: North America Hemostasis Valves Market Attractiveness, by End User, 2019–2027
Figure 33: Europe Hemostasis Valves Market Value (US$ Mn), 2017–2027
Figure 34: Europe Hemostasis Valves Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 35: Europe Hemostasis Valves Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 36: Europe Hemostasis Valves Market Value Share (%), by Application, 2018 and 2027
Figure 37: Europe Hemostasis Valves Market Attractiveness, by Application, 2019–2027
Figure 38: Europe Hemostasis Valves Market Value Share Analysis, by Product, 2018 and 2027
Figure 39: Europe Hemostasis Valves Market Attractiveness Analysis, by Product, 2019–2027
Figure 40: Europe Hemostasis Valves Market Value Share (%), by End User, 2018 and 2027
Figure 41: Europe Hemostasis Valves Market Attractiveness, by End User, 2019–2027
Figure 42: Asia Pacific Hemostasis Valves Market Value (US$ Mn), 2017–2027
Figure 43: Asia Pacific Hemostasis Valves Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 44: Asia Pacific Hemostasis Valves Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 45: Asia Pacific Hemostasis Valves Market Value Share (%), by Application, 2018 and 2027
Figure 46: Asia Pacific Hemostasis Valves Market Attractiveness, by Application, 2019–2027
Figure 47: Asia Pacific Hemostasis Valves Market Value Share Analysis, by Product, 2018 and 2027
Figure 48: Asia Pacific Hemostasis Valves Market Attractiveness Analysis, by Product, 2019–2027
Figure 49: Asia Pacific Hemostasis Valves Market Value Share (%), by End User, 2018 and 2027
Figure 50: Asia Pacific Hemostasis Valves Market Attractiveness, by End User, 2019–2027
Figure 51: Latin America Hemostasis Valves Market Value (US$ Mn), 2017–2027
Figure 52: Latin America Hemostasis Valves Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 53: Latin America Hemostasis Valves Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 54: Latin America Hemostasis Valves Market Value Share (%), by Application, 2018 and 2027
Figure 55: Latin America Hemostasis Valves Market Attractiveness, by Application, 2019–2027
Figure 56: Latin America Hemostasis Valves Market Value Share Analysis, by Product, 2018 and 2027
Figure 57: Latin America Hemostasis Valves Market Attractiveness Analysis, by Product, 2019–2027
Figure 58: Latin America Hemostasis Valves Market Value Share (%), by End User, 2018 and 2027
Figure 59: Latin America Hemostasis Valves Market Attractiveness, by End User, 2019–2027
Figure 60: Middle East and Africa Hemostasis Valves Market Value (US$ Mn), 2017–2027
Figure 61: Middle East & Africa Hemostasis Valves Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 62: Middle East & Africa Hemostasis Valves Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 63: Middle East & Africa Hemostasis Valves Market Value Share (%), by Application, 2018 and 2027
Figure 64: Middle East & Africa Hemostasis Valves Market Attractiveness, by Application, 2019–2027
Figure 65: Middle East & Africa Hemostasis Valves Market Value Share Analysis, by Product, 2018 and 2027
Figure 66: Middle East & Africa Hemostasis Valves Market Attractiveness Analysis, by Product, 2019–2027
Figure 67: Middle East & Africa Hemostasis Valves Market Value Share (%), by End User, 2018 and 2027
Figure 68: Middle East & Africa Hemostasis Valves Market Attractiveness, by End User, 2019–2027
Figure 69: B. Braun Melsungen AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: B. Braun Melsungen AG R&D Expenses (US$ Mn) 2016–2018
Figure 71: B. Braun Melsungen AG Breakdown of Net Sales, by Region/Country, 2018
Figure 72: B. Braun Melsungen AG Breakdown of Net Sales, by Business Division, 2018
Figure 73: Boston Scientific Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 74: Boston Scientific Corporation, R&D Intensity and Distribution & Administrative Intensity (%) –2017–2018
Figure 75: Boston Scientific Corporation, Breakdown of Net Sales, by Region 2018
Figure 76: Boston Scientific Corporation, Breakdown of Net Sales, by Businesses 2018
Figure 77: Teleflex Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 78: Teleflex Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 79: Teleflex Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 80: Terumo Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 81: Terumo Corporation R&D Expenses (US$ Mn) 2015–2017
Figure 82: Terumo Corporation Breakdown of Net Sales, by Region/Country, 2017
Figure 83: Terumo Corporation Breakdown of Net Sales, by Business Division, 2017
Figure 84: Merit Medical Systems, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 85: Merit Medical Systems, Inc. R&D Expenses (US$ Mn) 2015–2018
Figure 86: Merit Medical Systems, Inc. Breakdown of Net Sales, by Region/Country, 2018
Figure 87: Merit Medical Systems, Inc. Breakdown of Net Sales, by Business Division, 2018
